« Back
Home /
Rapamycin

Rapamycin

Item no.	M1768-200mg
Manufacturer	AbMole
CASRN	53123-88-9
Amount	200mg
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Bone Cancer
Type	Inhibitors
Specific against	other
Purity	0,9918
Citations	Retrospective Comparison of Midterm Clinical and Angiographic Outcomes after the Implantation of Paclitaxel- and Sirolimus-Eluting Stents for de novo Coronary Complex Lesions in Nonrandomized Japanese Patients. Ishikawa T, et al . Intern Med. 2012,51(19):2695-701. PMID: 23037458 . Impact of Tacrolimus-Sirolimus Maintenance Immunosuppression on Proteinuria and Kidney Function in Pancreas Transplant Alone Recipients. Kandula P, et al . Transplantation. 2012 Oct 3. PMID: 23037007 . Comparison of zotarolimus-eluting and sirolimus-eluting coronary stents: a study from the Western Denmark Heart Registry. Maeng M, et al . BMC Cardiovasc Disord. 2012 Oct 2,12(1):84. PMID: 23031197 . Topical use of rapamycin in herpetic stromal keratitis. Zapata G, et al . Ocul Immunol Inflamm. 2012 Oct,20(5):354-9. PMID: 23030354 .
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	Sirolimus, Rapamune
Similar products	Rapamycin, Sirolimus, Rapamune
Available
Molecular Weight	914, 18
Solubility	DMSO 80 mg/mL
Bioactivity information	Rapamycin (Sirolimus, Rapamune)is an inhibitor of mTOR.The mammalian target of rapamycin (mTOR) is a kinase responsible for mitogen-induced cell proliferation/survival signaling.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

M1768-200mg-safety-datasheet.pdf